News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Breast Cancer Cells Credit Min Yu 547x410
Longer course of hormonal therapy before surgery for breast cancer has greater impact on tumour growth

23/03/22

Treating some women with higher risk breast cancer with a longer course of hormonal therapy before surgery led to more changes in the genetic makeup of their tumours, some of which were associated with better survival outcomes.
Group of people listening to a talk
ICR Discovery Club showcases how we take new drugs to cancer patients

22/03/22

Members of the Discovery Club gathered at the Royal Society of Chemistry to hear how our scientists are moving new cancer drugs into the clinic.
Blue man van offering free health checks to men
'Man Van' launched to speed up early diagnosis of prostate cancer and improve healthcare access

21/03/22

​The 'Man Van', an innovative new outreach programme, has been launched today to provide free health checks for men and boost early diagnosis of prostate and other urological cancers.
Breast cancer cell
Spinal fluid analysis could speed up diagnosis of breast cancer spread

21/03/22

Analysing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study.
Split image of Sir Richard Doll building in Sutton and Imperial College building in South Kensington 547x410
Cancer Research UK renew support for Convergence Science Centre

21/03/22

Renewed Cancer Research UK funding for Convergence Science Centre at the ICR and Imperial will build on existing partnership by uniting cancer researchers with engineers and physical scientists to tackle cancer’s toughest challenges.
Breast cancer cells on a black background
ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation

16/03/22

The ICR strongly welcomes new findings that the targeted drug olaparib improves survival in women with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.
Collage of researchers Camilla Rega, Vivian Dimou, Dani Chattenton and Ana Padilha pursuing their passions
#BreakTheBias: Scientists showcase their lives outside the lab

08/03/22

What do scientists look like? This International Women’s Day, we are introducing some of our researchers to help #BreakTheBias, and showcasing the full lives and passions of our scientists outside the lab – from dancing and baking to running or playing an instrument.
Innovation Gateway at The London Cancer Hub
New home for innovative life-science companies opens at The London Cancer Hub

24/02/22

A new incubator and collaboration space for innovative life-science companies whose work is relevant to cancer is opening its doors at The London Cancer Hub in Sutton, south London.
ICR Logo
NHS gene testing does not detect half of people at cancer risk

21/02/22

NHS guidelines for gene testing miss half of people carrying inherited genetic changes linked to cancer, a new study reports.
White abiraterone pill
NICE misses golden opportunity to enhance access to innovative cancer drugs

07/02/22

Cancer patients will miss out on exciting new treatments after NICE passed up a golden opportunity to ensure its evaluation methods support approval of the most innovative, potentially game-changing drugs.
High Intensity Focused Ultrasound machine
Focused sound waves and immunotherapy combination shows promise in pancreatic cancers

07/02/22

Combining targeted, focused ultrasound and immunotherapy drugs could work as a new treatment for pancreatic cancers, a new study has shown.
Graduation students at Senate House 2017
ICR ranks top in UK for student satisfaction

07/02/22

Students on our MSc taught course and postgraduate research degree programmes have again ranked The Institute of Cancer Research, London, top nationally for student satisfaction in their respective surveys.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.